U.S. Chemical & Life Science Patents Q1 – 2026 Newsletter
TO READ THE LATEST ISSUE CLICK HERE
Harness IP’s Q1 2026 Chemical & Life Sciences Newsletter examines critical developments at the intersection of patent law, regulatory policy, and innovation strategy. This edition covers the Supreme Court’s upcoming review of skinny labeling liability, evolving Federal Circuit guidance on written description, enablement, and patent eligibility, and important USPTO procedural changes—alongside practical takeaways for protecting life sciences innovations.
WHAT’S INSIDE:
US Chemical & Life Sciences Case Law Updates
- U.S. Supreme Court To Hear Skinny Labeling Patent Case
- Federal Circuit Maintains Stricter Stance on Written Description and Enablement Support for Chemical Molecules
- Federal Circuit Finds District Court Applied Overly Narrow §101 Analysis to Recombinant Composition
USPTO Updates
- USPTO is amending the patent rules to require foreign patent applicants to be represented by USPTO-registered practitioners
- USPTO extends Patent Prosecution Highway pilot program
- USPTO has moved the Automated Interview Request (AIR) tool to Patent Center
- USPTO now requires patent applicants to opt-in to receive courtesy ceremonial copy of patent eGrants
Harness IP Updates
- A Practical Guide to Patent Prosecution (training program)
- Green Patent Programs (blog series)
For more updates on Chemical and Life Science law read the previous CLS Newsletters here.
SUBSCRIBE and get the latest insights delivered directly to your inbox!